The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Effect of indacaterol on exercise endurance and lung hyperinflation in COPD
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By increasing resting IC, bronchodilators also increase the available dynamic IRV and thereby delay the onset of critical respiratory-mechanical constraints on V T expansion (and thereby _ V E) during exercise [60,78,79,90,91].”
From Lung hyperinflation in COPD: applying physiology to clinical practice (2015) · cites this paper as [90]
In the citing paper
“Thus, for any given exercise intensity or _ V E, patients breathe on the more linear portion of the respiratory system's pressure-volume curve, which delays the onset of neuromechanical dissociation and the attendant dyspnea [60,78,79,90].”
From Lung hyperinflation in COPD: applying physiology to clinical practice (2015) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
Self-citationO'DONNELL, D. E., LAM, M., & WEBB, K. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9804004 · Cited by 532 · cited 10×
“While these treatmenteplacebo differences were less than those observed in the previous tiotropium study (tiotropiumeplacebo differences of 210e250 mL),16 the tiotropium study recruited a larger proportion of patients with severe COPD.”
InfluentialSelf-citationO'DONNELL, D. E., LAM, M., & WEBB, K. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9901038 · Cited by 485
Self-citationThe major limitation to exercise performance in COPD is dynamic hyperinflation
O'Donnell, D. E., & Webb, K. A. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90336.2008b · Cited by 221
Self-citation
Research works printed but not linked: 18
- O’Donnell, 1999, Spirometric correlates of improvement in exercise performance after anticholinergic therapy in COPD, Am J Respir Crit Care Med, 160, 542
- Esteban, 2010, Impact of changes in physical activity on health-related quality of life among patients with chronic obstructive pulmonary disease, Eur Respir J, 36, 292
- Neder, 2007, Effects of formoterol on exercise tolerance in severely disabled patients with COPD, Respir Med, 101, 2056
- Maltais, 2005, Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD, Chest, 128, 1168
- Cazzola, 2005, Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease, Expert Opin Investig Drugs, 14, 775
- Dahl, 2010, Efficacy of a new once-daily long-acting inhaled β2-agonist indacaterol versus twice-daily formoterol in COPD, Thorax, 65, 473
- Donohue, 2010, Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium, Am J Respir Crit Care Med, 182, 155
- Feldman, 2010, Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study, BMC Pulm Med, 10, 11
- Quanjer, 1993, Lung volumes and forced ventilatory flows, Eur Respir J, 6, 5
- 2003, ATS/ACCP statement on cardiopulmonary exercise testing, Am J Respir Crit Care Med, 167, 211
- O’Donnell, 2004, Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD, Eur Respir J, 23, 832
- Puente-Maestu, 2009, Clinical relevance of constant power exercise duration changes in COPD, Eur Respir J, 34, 340
- O’Donnell, 2009, Reliability of ventilatory parameters during cycle ergometry in multicenter trials in COPD, Eur Respir J, 34, 866
- Oga, 2007, Longitudinal deteriorations in patient reported outcomes in patients with COPD, Respir Med, 101, 146
- Kesten, 2008, Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients, Int J COPD, 3, 127
- Pasqua, 2010, Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: a pilot study, Resp Med, 104, 412
- Vogiatzis, 2008, Chest wall volume regulation during exercise in COPD patients with GOLD stages II to IV, Eur Respir J, 32, 42
- Kornmann, 2011, Once daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison, Eur Resp J, 37, 273
Cited by
Spruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citationAn official European Respiratory Society statement on physical activity in COPD
Watz, H., Pitta, F., Rochester, C. L., Garcia-Aymerich, J., ZuWallack, R., Troosters, T., Vaes, A. W., Puhan, M. A., Jehn, M., Polkey, M. I., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00046814 · Cited by 526
Self-citationImproving physical activity in COPD: towards a new paradigm
Troosters, T., van der Molen, T., Polkey, M., Rabinovich, R. A., Vogiatzis, I., Weisman, I., & Kulich, K. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-115 · Cited by 158
Gimeno-Santos, E., Raste, Y., Demeyer, H., Louvaris, Z., de Jong, C., Rabinovich, R. A., Hopkinson, N. S., Polkey, M. I., Vogiatzis, I., Tabberer, M., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00183014 · Cited by 151
Berry, M. J., Justus, N. W., Hauser, J. I., Case, A. H., Helms, C. C., Basu, S., Rogers, Z., Lewis, M. T., & Miller, G. D. (2015) · Nitric Oxide · doi:10.1016/j.niox.2014.10.007 · Cited by 134
Metadata
- Authors
- O’Donnell, D. E., Casaburi, R., Vincken, W., Puente-Maestu, L., Swales, J., Lawrence, D., & Kramer, B.
- Venue
- Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 105
- Issue
- 7
- Pages
- 1030-1036
- ISSN
- 0954-6111
- Cited by
- 109
- References
- 4
- Language
- en
- Licence
- Funders
- Novartis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. https://app.cochat.ai/papers/10.1016/j.rmed.2011.03.014
- The paper
- O’Donnell, D. E., Casaburi, R., Vincken, W., Puente-Maestu, L., Swales, J., Lawrence, D., & Kramer, B. (2011). Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respiratory Medicine. https://doi.org/10.1016/j.rmed.2011.03.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
